Table 3.
ATA risk classification according to the responses to therapy.
| ATA risk classification | n (%) | Excellent response (n = 461) | Indeterminate response (n = 65) | Biochemicalincomplete response (n = 83) | Structural incomplete (n = 65) | p-values |
|---|---|---|---|---|---|---|
| Low risk | 404 (60.0%) | 318 (68.9%) | 36 (55.4%) | 44 (53.0%) | 6 (9.2%) | <0.001 |
| Intermediate risk | 127 (18.8%) | 76 (16.5%) | 14 (21.5%) | 18 (21.7%) | 19 (29.2%) | |
| High risk | 143 (21.2%) | 67 (14.5%) | 15 (23.1%) | 21 (25.3%) | 40 (61.5%) |
Significant differences in the proportions (p-value) were determined by chi-square analysis.
ATA, American Thyroid Association.